{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:37:47Z","timestamp":1779237467999,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"am","delay-in-days":285,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.metabol.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T12:48:43Z","timestamp":1483706923000},"page":"33-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects"],"prefix":"10.1016","volume":"69","author":[{"given":"Andrea","family":"Natali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Trifir\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Tric\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2017.01.001_bb0005","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.2337\/diabetes.52.10.2490","article-title":"Insulin sensitivity, insulin secretion, and abdominal fat: the insulin resistance atherosclerosis study (IRAS) family study","volume":"52","author":"Wagenknecht","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2017.01.001_bb0010","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1210\/jc.2007-0334","article-title":"Insulin resistance, insulin response, and obesity as indicators of metabolic risk","volume":"92","author":"Ferrannini","year":"2007","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.metabol.2017.01.001_bb0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/MOL.0b013e328339387b","article-title":"HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus","volume":"21","author":"Kruit","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2017.01.001_bb0020","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/dom.12049","article-title":"Components of metabolic syndrome and 5-year change in insulin clearance - the insulin resistance atherosclerosis study","volume":"15","author":"Lee","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2017.01.001_bb0025","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/ATVBAHA.110.207373","article-title":"Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion","volume":"30","author":"Fryirs","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2017.01.001_bb0030","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00125-007-0642-z","article-title":"Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells","volume":"50","author":"Abderrahmani","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2017.01.001_bb0035","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.108.843219","article-title":"High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus","volume":"119","author":"Drew","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2017.01.001_bb0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/CIRCULATIONAHA.111.018259","article-title":"Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the investigation of lipid level management to understand its impact in atherosclerotic events (ILLUMINATE) trial","volume":"124","author":"Barter","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2017.01.001_bb0045","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2337\/db14-1710","article-title":"Using genetic variants to assess the relationship between circulating lipids and type 2 diabetes","volume":"64","author":"Fall","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2017.01.001_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11010-012-1402-z","article-title":"NADPH oxidase 2 plays a critical role in dysfunction and apoptosis of pancreatic beta-cells induced by very low-density lipoprotein","volume":"370","author":"Jiao","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.metabol.2017.01.001_bb0055","doi-asserted-by":"crossref","first-page":"E653","DOI":"10.1152\/ajpendo.00680.2013","article-title":"Blood lipids affect rat islet blood flow regulation through beta(3)-adrenoceptors","volume":"307","author":"Lai","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.01.001_bb0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/endo.133.1.8319569","article-title":"Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release","volume":"133","author":"Elks","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2017.01.001_bb0065","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1172\/JCI118727","article-title":"Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat","volume":"97","author":"Stein","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2017.01.001_bb0070","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1210\/endo-127-4-1580","article-title":"A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation","volume":"127","author":"Sako","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2017.01.001_bb0075","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2337\/diabetes.48.3.524","article-title":"Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats","volume":"48","author":"Mason","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2017.01.001_bb0080","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1007\/s00125-015-3685-6","article-title":"Influence of endogenous NEFA on beta cell function in humans","volume":"58","author":"Rebelos","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2017.01.001_bb0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/diabetes.49.3.399","article-title":"Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes","volume":"49","author":"Carpentier","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2017.01.001_bb0090","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/diabetes.52.10.2461","article-title":"A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes","volume":"52","author":"Kashyap","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2017.01.001_bb0095","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1079\/BJN20041268","article-title":"The ingestion of saturated fatty acid triacylglycerols acutely affects insulin secretion and insulin sensitivity in human subjects","volume":"92","author":"Manco","year":"2004","journal-title":"Br J Nutr"},{"key":"10.1016\/j.metabol.2017.01.001_bb0100","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.2337\/dc12-1203","article-title":"Hepatic insulin clearance is closely related to metabolic syndrome components","volume":"36","author":"Pivovarova","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2017.01.001_bb0105","doi-asserted-by":"crossref","first-page":"E1709","DOI":"10.1152\/ajpendo.00444.2007","article-title":"Effect of liver fat on insulin clearance","volume":"293","author":"Kotronen","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.01.001_bb0110","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/db07-0056","article-title":"Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction","volume":"56","author":"Hao","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2017.01.001_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2017.01.001_bb0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","article-title":"Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6year follow-up study of the METSIM cohort","volume":"58","author":"Cederberg","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2017.01.001_bb0125","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-004-1335-5","article-title":"The EGIR-RISC study (the European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I methodology and objectives","volume":"47","author":"Hills","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2017.01.001_bb0130","doi-asserted-by":"crossref","first-page":"E1159","DOI":"10.1152\/ajpendo.00093.2002","article-title":"Meal and oral glucose tests for the assessment of \u00df-cell function: modeling analysis in normal subjects","volume":"283","author":"Mari","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.01.001_bb0135","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","article-title":"Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance","volume":"41","author":"Van Cauter","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2017.01.001_bb0140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nm1546","article-title":"Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment","volume":"13","author":"Brunham","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2017.01.001_bb0145","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s00125-010-1691-2","article-title":"Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice","volume":"53","author":"Kruit","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2017.01.001_bb0150","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus","volume":"313","author":"Besseling","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2017.01.001_bb0155","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1600-6143.2009.02644.x","article-title":"The effect of rosuvastatin on insulin sensitivity and pancreatic beta-cell function in nondiabetic renal transplant recipients","volume":"9","author":"Sharif","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.metabol.2017.01.001_bb0160","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.2337\/diabetes.51.8.2596","article-title":"Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes","volume":"51","author":"Paniagua","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2017.01.001_bb0165","doi-asserted-by":"crossref","first-page":"e0142902","DOI":"10.1371\/journal.pone.0142902","article-title":"Simvastatin impairs insulin secretion by multiple mechanisms in MIN6 cells","volume":"10","author":"Yaluri","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2017.01.001_bb0170","doi-asserted-by":"crossref","first-page":"E541","DOI":"10.1152\/ajpendo.00175.2004","article-title":"Characterization of \u03b2-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests","volume":"288","author":"Mari","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.01.001_bb0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCRESAHA.113.300689","article-title":"Effects of high-density lipoprotein elevation with cholesteryl ester transfer protein inhibition on insulin secretion","volume":"113","author":"Siebel","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2017.01.001_bb0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/db14-0436","article-title":"Loss-of-function mutations in ABCA1 and enhanced beta-cell secretory capacity in young adults","volume":"64","author":"Rickels","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2017.01.001_bb0185","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids","volume":"278","author":"Briscoe","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2017.01.001_bb0190","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2015.03.034","article-title":"Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men","volume":"240","author":"Fizelova","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2017.01.001_bb0195","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.0000126824.12785.B6","article-title":"Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease","volume":"109","author":"Tenenbaum","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2017.01.001_bb0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2006.08.005","article-title":"Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes","volume":"194","author":"Tenenbaum","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2017.01.001_bb0205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00125-012-2776-x","article-title":"Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes","volume":"56","author":"Kang","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2017.01.001_bb0210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.mol.0000226115.97436.c0","article-title":"Diabetic dyslipidaemia","volume":"17","author":"Adiels","year":"2006","journal-title":"Curr Opin Lipidol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517300033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517300033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:12:08Z","timestamp":1758427928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049517300033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":42,"alternative-id":["S0026049517300033"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2017.01.001","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}